Prostate Cancer Risk: Overview of the Disease, Predictive Factors, and Potential Targets for Risk ReductionANDRIOLE, Gerald L.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, issn 0090-4295, 45 p., SUPSerial Issue

Cost-Effectiveness of Prostate Specific Antigen Screening in the United States: Extrapolating From the European Study of Screening for Prostate CancerSHTEYNSHLYUGER, Alex; ANDRIOLE, Gerald L.The Journal of urology. 2011, Vol 185, Num 3, pp 828-832, issn 0022-5347, 5 p.Article

Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in thetreatment of benign prostatic hyperplasiaANDRIOLE, Gerald L; KIRBY, Roger.European urology. 2003, Vol 44, Num 1, pp 82-88, issn 0302-2838, 7 p.Article

Prostate cancer chemoprevention with 5α-reductase inhibitorsNEPPLE, Kenneth G; ANDRIOLE, Gerald L.Urologic oncology. 2012, Vol 30, Num 5, pp 553-554, issn 1078-1439, 2 p.Article

Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5α-reductase inhibitor dutasterideANDRIOLE, Gerald L; MARBERGERT, Michael; ROEHRBORN, Claus G et al.The Journal of urology. 2006, Vol 175, Num 5, pp 1657-1662, issn 0022-5347, 6 p.Article

Critical Appraisal of Prostate-specific Antigen in Prostate Cancer Screening: 20 Years LaterPIENTA, Kenneth J.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 11-20, issn 0090-4295, 10 p., SUPArticle

Risk of Developing Prostate Cancer in the Future: Overview of Prognostic BiomarkersFLESHNER, Neil E; LAWRENTSCHUK, Nathan.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 21-27, issn 0090-4295, 7 p., SUPArticle

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trialPINSKY, Paul F; PARNES, Howard L; ANDRIOLE, Gerald et al.BJU international (Papier). 2014, Vol 113, Num 2, pp 254-259, issn 1464-4096, 6 p.Article

Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate CancerCRAWFORD, E. David.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 4-10, issn 0090-4295, 7 p., SUPArticle

Prevention of benign prostatic hyperplasia diseaseMARKS, Leonard S; ROEHRBORN, Claus G; ANDRIOLE, Gerald L et al.The Journal of urology. 2006, Vol 176, Num 4, pp 1299-1306, issn 0022-5347, 8 p., 1Article

Application of a fixed retractor system to facilitate laparoscopic radical prostatectomyLANDMAN, Jaime; VENKATESH, Ramakrishna; VANLANGENDONCK, Richard et al.The Journal of urology. 2004, Vol 171, Num 2, pp 783-785, issn 0022-5347, 3 p., 1Article

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3GARCIA-CLOSAS, Montserrat; YUANQING YE; REAL, Francisco X et al.Human molecular genetics (Print). 2011, Vol 20, Num 21, pp 4282-4289, issn 0964-6906, 8 p.Article

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective ICF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansSCHUMACHER, Fredrick R; CHENG, Iona; HUNTER, David J et al.Human molecular genetics (Print). 2010, Vol 19, Num 15, pp 3089-3101, issn 0964-6906, 13 p.Article

Sequence variants of estrogen receptor β and risk of prostate cancer in the national cancer institute breast and prostate cancer cohort consortiumCHEN, Yen-Ching; KRAFT, Peter; BURTT, Noel et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 10, pp 1973-1981, issn 1055-9965, 9 p.Article

The effects of 5α-reductase inhibitors on the natural history, detection and grading of prostate cancer : Current state of knowledgeANDRIOLE, Gerald; BOSTWICK, David; CIVANTOS, Francisco et al.The Journal of urology. 2005, Vol 174, Num 6, pp 2098-2104, issn 0022-5347, 7 p.Article

Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trialANDRIOLE, Gerald; BOSTWICK, David; BRAWLEY, Otis et al.The Journal of urology. 2004, Vol 172, Num 4, pp 1314-1317, issn 0022-5347, 4 p., 1Article

Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasiaANDRIOLE, Gerald; BRUCHOVSKY, Nicholas; CHUNG, Leland W. K et al.The Journal of urology. 2004, Vol 172, Num 4, pp 1399-1403, issn 0022-5347, 5 p., 1Article

Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder CancerGARCIA-CLOSAS, Montserrat; ROTHMAN, Nathaniel; PURDUE, Mark P et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 7, pp 2211-2220, issn 0008-5472, 10 p.Article

Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)LINDSTRÖM, Sara; SCHUMACHER, Fredrick R; DAVID CRAWFORD, E et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 3, pp 437-444, issn 1055-9965, 8 p.Article

Replication of Five Prostate Cancer Loci Identified in an Asian Population—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)LINDSTRÖM, Sara; SCHUMACHER, Fredrick R; GAPSTUR, Susan M et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 1, pp 212-216, issn 1055-9965, 5 p.Article

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. CommentaryPLATZ, Elizabeth A; SCHUMACHER, Fredrick R; DIVER, W. Ryan et al.Cancer research (Baltimore). 2007, Vol 67, Num 7, issn 0008-5472, 2905-2907,2951-2956 [9 p.]Article

Overdiagnosis of Prostate CancerSANDHU, Gurdarshan S; ANDRIOLE, Gerald L.Journal of the National Cancer Institute. Monographs. 2012, Vol 45, pp 146-151, issn 1052-6773, 6 p.Conference Paper

Reduction in the Risk of Prostate Cancer: Future Directions After the Prostate Cancer Prevention Trial. CommentaryCRAWFORD, E. David; ANDRIOLE, Gerald L; MARBERGER, Michael et al.Urology (Ridgewood, NJ). 2010, Vol 75, Num 3, pp 502-510, issn 0090-4295, 9 p.Article

Current Prostate Cancer Treatments: Effect on Quality of LifeGOMELLA, Leonard G; JOHANNES, James; TRABULSI, Edouard J et al.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 28-35, issn 0090-4295, 8 p., SUPArticle

Alcohol Intake Increases High-grade Prostate Cancer Risk Among Men Taking Dutasteride in the REDUCE TrialFOWKE, Jay H; HOWARD, Lauren; ANDRIOLE, Gerald L et al.European urology. 2014, Vol 66, Num 6, pp 1133-1138, issn 0302-2838, 6 p.Article